BWX Technologies Reports Second Quarter 2026 Results
LYNCHBURG, Va. -BWX Technologies, Inc. (NYSE: BWXT) (“BWXT”, “we”, “us” or the “Company”) reported second quarter 2026 results. A reconciliation of non-GAAP results is detailed in Exhibit 1.
BWXT Selling Medical Business to Nordic Capital in Transaction Valued at up to $800 Million
(LYNCHBURG, Va. – Aug. 3, 2026) BWX Technologies, Inc. (NYSE: BWXT) announced today it has entered into a definitive agreement to sell its medical business to Nordic Capital, an experienced healthcare investor with broad expertise and a deep understanding of the radiopharmaceutical industry and its value chain. The transaction, valued at up to $800 million, includes BWXT Medical and Kinectrics’ stable medical isotopes business.